Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.


TSX:ONC - Post by User

Bullboard Posts
Comment by bilosellhion Jun 03, 2004 8:17pm
250 Views
Post# 7570214

RE: MORE on AGM

RE: MORE on AGMBilo...I didn’t know that you were an aspiring drug clinician and pharmacologist however. Were you wearing a tie when you wrote todays posts? actually i figured if beancounters lievonen & ball can do it, i shouldn't be afraid to at least try Personally, I’d rather take your investment advice than your designer advice with respect to virus oncology trials. that is probably not going too far out on a limb on your part, but i do think my larger point that management's clinical trial strategy seems disjointed at best and derailed at times (glio delays, slowness in deciding what results they were looking for from the prostate trial, etc.) stands. hopefully the UK & NIH trials will start to change that perception if not reality, while the results add some credibility. Investment wise, ….. have you taken any money off the table yet? i've taken some money off the table but replaced those shares with cheaper ones so i'm still at my core position with a lower net. seems like $5 US is holding pretty well and the start of the UK trials should imo, help support that level. without volume though, which probably won't happen without news (like Cdn ph I glio results), i think it is stuck in a trading range.
Bullboard Posts